Sandra Calvin

CIK: 0001882909

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)17 (47.2%)

Position reduction

Option Exercises (M)17 (47.2%)

Derivative conversions

Awards (A)2 (5.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TVTX

Travere Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (36 total)

TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Exercise(M)
Direct
2.5K shares at avg. $27.50$69K
TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
300 shares at avg. $63.66$19K
TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
800 shares at avg. $62.85$50K
TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Sale(S)
Direct
4.3K shares at avg. $62.13$266K
TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Exercise(M)
Direct
1.6K shares at avg. $20.46$33K
TVTX
Travere Therapeutics, Inc.
Sep 15, 2026
Exercise(M)
Direct
1.3K shares at avg. $22.40$28K
TVTX
Travere Therapeutics, Inc.
Apr 14, 2026
Sale(S)
Direct
22K shares at avg. $41.07$903K
TVTX
Travere Therapeutics, Inc.
Apr 14, 2026
Exercise(M)
Direct
2.5K shares at avg. $22.40$56K
TVTX
Travere Therapeutics, Inc.
Apr 14, 2026
Exercise(M)
Direct
6.3K shares at avg. $8.93$56K
TVTX
Travere Therapeutics, Inc.
Apr 14, 2026
Exercise(M)
Direct
6.5K shares at avg. $20.46$133K
TVTX
Travere Therapeutics, Inc.
Feb 3, 2026
Sale(S)
Direct
4.3K shares at avg. $32.12$139K
TVTX
Travere Therapeutics, Inc.
Jan 31, 2026
Award(A)
Direct
15.2K shares-
TVTX
Travere Therapeutics, Inc.
Dec 24, 2025
Sale(S)
Direct
7.4K shares at avg. $40.00$296K
TVTX
Travere Therapeutics, Inc.
Dec 15, 2025
Sale(S)
Direct
2.9K shares at avg. $36.00$105K
TVTX
Travere Therapeutics, Inc.
Nov 4, 2025
Exercise(M)
Direct
15K shares at avg. $27.50$413K
TVTX
Travere Therapeutics, Inc.
Nov 4, 2025
Exercise(M)
Direct
12.5K shares at avg. $22.40$280K
TVTX
Travere Therapeutics, Inc.
Nov 4, 2025
Exercise(M)
Direct
17.5K shares at avg. $26.88$470K
TVTX
Travere Therapeutics, Inc.
Nov 4, 2025
Sale(S)
Direct
67.1K shares at avg. $36.00$2.4M
TVTX
Travere Therapeutics, Inc.
Nov 4, 2025
Exercise(M)
Direct
10K shares at avg. $25.25$253K
TVTX
Travere Therapeutics, Inc.
Nov 4, 2025
Exercise(M)
Direct
6.3K shares at avg. $8.93$56K
TVTX
Travere Therapeutics, Inc.
Feb 11, 2025
Exercise(M)
Direct
10K shares at avg. $17.96$180K
TVTX
Travere Therapeutics, Inc.
Feb 11, 2025
Sale(S)
Direct
9.2K shares at avg. $25.00$231K
TVTX
Travere Therapeutics, Inc.
Feb 11, 2025
Sale(S)
Direct
15K shares at avg. $25.00$375K
TVTX
Travere Therapeutics, Inc.
Feb 11, 2025
Exercise(M)
Direct
15K shares at avg. $15.46$232K
TVTX
Travere Therapeutics, Inc.
Feb 11, 2025
Sale(S)
Direct
10K shares at avg. $25.00$250K

		Type	Shares	Price		Ownership
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	2,500	$27.50	$68,750	Direct
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	300	$63.66	$19,099	Direct
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	800	$62.85	$50,278	Direct
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	4,275	$62.13	$265,627	Direct
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	1,625	$20.46	$33,248	Direct
Sep 15, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	1,250	$22.40	$28,000	Direct
Apr 14, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	21,977	$41.07	$902,595	Direct
Apr 14, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	2,500	$22.40	$56,000	Direct
Apr 14, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	6,250	$8.93	$55,813	Direct
Apr 14, 2026	TVTX Travere Therapeutics, Inc.	Exercise(M)	6,500	$20.46	$132,990	Direct
Feb 3, 2026	TVTX Travere Therapeutics, Inc.	Sale(S)	4,333	$32.12	$139,176	Direct
Jan 31, 2026	TVTX Travere Therapeutics, Inc.	Award(A)	15,180	-	$0	Direct
Dec 24, 2025	TVTX Travere Therapeutics, Inc.	Sale(S)	7,402	$40.00	$296,080	Direct
Dec 15, 2025	TVTX Travere Therapeutics, Inc.	Sale(S)	2,910	$36.00	$104,760	Direct
Nov 4, 2025	TVTX Travere Therapeutics, Inc.	Exercise(M)	15,000	$27.50	$412,500	Direct
Nov 4, 2025	TVTX Travere Therapeutics, Inc.	Exercise(M)	12,500	$22.40	$280,000	Direct
Nov 4, 2025	TVTX Travere Therapeutics, Inc.	Exercise(M)	17,500	$26.88	$470,400	Direct
Nov 4, 2025	TVTX Travere Therapeutics, Inc.	Sale(S)	67,115	$36.00	$2,416,140	Direct
Nov 4, 2025	TVTX Travere Therapeutics, Inc.	Exercise(M)	10,000	$25.25	$252,500	Direct
Nov 4, 2025	TVTX Travere Therapeutics, Inc.	Exercise(M)	6,250	$8.93	$55,813	Direct
Feb 11, 2025	TVTX Travere Therapeutics, Inc.	Exercise(M)	10,000	$17.96	$179,600	Direct
Feb 11, 2025	TVTX Travere Therapeutics, Inc.	Sale(S)	9,244	$25.00	$231,100	Direct
Feb 11, 2025	TVTX Travere Therapeutics, Inc.	Sale(S)	15,000	$25.00	$375,000	Direct
Feb 11, 2025	TVTX Travere Therapeutics, Inc.	Exercise(M)	15,000	$15.46	$231,900	Direct
Feb 11, 2025	TVTX Travere Therapeutics, Inc.	Sale(S)	10,000	$25.00	$250,000	Direct

1-25 of 36 transactions

About Calvin Sandra

Calvin Sandra (SEC CIK 0001882909) files insider reports with the SEC as SVP, CHIEF ACCOUNTING OFFICER of Travere Therapeutics, Inc. (TVTX).

Signal8 holds 11 ownership filings by Calvin Sandra, all Form 4s, filed between Nov 25, 2024 and Sep 17, 2026. Those filings report 36 transactions, from Nov 25, 2024 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Calvin Sandra's filings is in SAN DIEGO, CA.

Recent filings by Calvin Sandra

Sep 15, 2026: Option exercise of TVTX shares (Form 4, code M).
Sep 15, 2026: Open-market sales of TVTX shares (3 lines, Form 4, code S).
Sep 15, 2026: Option exercises of TVTX shares (2 lines, Form 4, code M).
Apr 14, 2026: Open-market sale of TVTX shares (Form 4, code S).
Apr 14, 2026: Option exercises of TVTX shares (3 lines, Form 4, code M).

Other insiders filing for Travere Therapeutics, Inc. (TVTX)

Dube Eric M, CHIEF EXECUTIVE OFFICER
ROTE WILLIAM E., Chief Research Officer
Heerma Peter, EVP, CHIEF COMMERCIAL OFFICER
Inrig Jula, EVP, Head of R&D & CMO
REED ELIZABETH E, Chief Legal Officer and GC
Cline Christopher R., CHIEF FINANCIAL OFFICER

How to read Form 4 transaction codes